SCHEMBL20188098

SCHEMBL20188098

CCOC(=O)c1ccc(N2CCN(c3ccc(C(=O)OCC)cc3)CCN(c3ccc(C(=O)OCC)cc3)CCN(c3ccc(C(=O)OCC)cc3)CC2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.65
HTT P42858 2/20 0.65
ALDH1A1 P00352 5/20 0.61
HSP90AA1 P07900 1/20 0.61
CACNA1B Q00975 1/20 0.61
APBA1 Q02410 1/20 0.61
NPSR1 Q6W5P4 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
TSHR P16473 1/20 0.60
LMNA P02545 3/20 0.59
MAPT P10636 2/20 0.59
KDM4E B2RXH2 1/20 0.59
GAA P10253 1/20 0.59
CA12 O43570 1/20 0.59
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
ESR1 P03372 1/20 0.59
CA7 P43166 1/20 0.59
CA9 Q16790 1/20 0.59
ESR2 Q92731 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22015905 1.00 HPGD (0.65) HPGDHTTALDH1A1HSP90AA1CACNA1B
SCHEMBL20187714 0.95 HPGD (0.59) HPGDHTTALDH1A1HSP90AA1CACNA1B
SCHEMBL5324137 0.94 CYP2C9 (0.62) HPGDHTTALDH1A1HSP90AA1CACNA1B
SCHEMBL3067260 0.94 ALDH1A1 (0.58) HPGDHTTALDH1A1HSP90AA1CACNA1B
SCHEMBL3898465 0.93 HPGD (0.61) HPGDHTTALDH1A1HSP90AA1CACNA1B
SCHEMBL28242074 0.93 HPGD (0.61) HPGDHTTALDH1A1HSP90AA1CACNA1B
SCHEMBL2943824 0.92 KMT2A (0.61) HPGDHTTALDH1A1HSP90AA1CACNA1B
SCHEMBL20639893 0.92 HPGD (0.56) HPGDHTTALDH1A1HSP90AA1CACNA1B
SCHEMBL10770347 0.92 HPGD (0.56) HPGDHTTALDH1A1HSP90AA1CACNA1B
SCHEMBL8703730 0.92 MAPT (0.73) HPGDHTTALDH1A1HSP90AA1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11274268-B2 Detergent compositions for removing heavy metals and formaldehyde FNG RESEARCH CO., LTD. (KR) 2022-03-15 US disclosed
US-11090247-B2 Compositions for protecting the skin from heavy metals and formaldehyde FNG RESEARCH CO., LTD. (KR) 2021-08-17 US disclosed
US-11090247-B2 Compositions for protecting the skin from heavy metals and formaldehyde FNG RESEARCH CO., LTD. (KR) 2021-08-17 US disclosed
US-20210207064-A1 COMPOUND FOR RESTORING CONTAMINATED SOIL OR CONTAMINATED WATER FNG RESEARCH CO., LTD. (KR) 2021-07-08 US disclosed
US-20210207064-A1 COMPOUND FOR RESTORING CONTAMINATED SOIL OR CONTAMINATED WATER FNG RESEARCH CO., LTD. (KR) 2021-07-08 US disclosed
EP-3778045-A1 COMPOUND FOR RESTORING CONTAMINATED SOIL OR CONTAMINATED WATER FNG Research Co., Ltd. (KR) 2021-02-17 EP disclosed
EP-3544953-A1 COMPOSITIONS FOR PROTECTING THE SKIN FROM HEAVY METALS AND FORMALDEHYDE FNG Research Co., Ltd. (KR) 2019-10-02 EP disclosed
EP-3538631-A1 DETERGENT COMPOSITIONS FOR REMOVING HEAVY METALS AND FORMALDEHYDE FNG Research Co., Ltd. (KR) 2019-09-18 EP disclosed
WO-2018174337-A1 DETERGENT COMPOSITIONS FOR REMOVING HEAVY METALS AND FORMALDEHYDE FNG RESEARCH CO., LTD. (KR) 2018-09-27 WO disclosed
WO-2018097431-A1 COMPOSITIONS FOR PROTECTING THE SKIN FROM HEAVY METALS AND FORMALDEHYDE FNG RESEARCH CO., LTD. (KR) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11090247-B2 Compositions for protecting the skin from heavy metals and formaldehyde FSCN1, SLC40A1, HCN2 HPGD 264/4885HTT 1627/4885ALDH1A1 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.